home / stock / adxs / adxs news


ADXS News and Press, Advaxis From 04/01/21

Stock Information

Company Name: Advaxis
Stock Symbol: ADXS
Market: NASDAQ
Website: advaxis.com

Menu

ADXS ADXS Quote ADXS Short ADXS News ADXS Articles ADXS Message Board
Get ADXS Alerts

News, Short Squeeze, Breakout and More Instantly...

ADXS - 5 Penny Stocks You Can Buy For Under $1 On Robinhood

Cheap Penny Stocks On Robinhood Are Hard To Come By Buying penny stocks on Robinhood has become the norm for many traders. Given the app’s easy set-up and clear-cut operating platform, millions of new retail traders have made it their go-to platform. I know there’ve be...

ADXS - Advaxis to Present Corporate Overview at the Benzinga Biotech Small Cap Conference

PRINCETON, N.J., March 23, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS ), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that Kenneth A. Berlin, President and Chief Executive Officer of Advaxis,...

ADXS - 3 Penny Stocks On Robinhood To Buy Under $1 Right Now?

Penny Stocks To Buy On Robinhood Under $1 In this article, we’ll discuss a few things. First, what are penny stocks , and second why would anyone want to buy them? I’ll also discuss a few popular penny stocks that have begun trending among Robinhood traders. Many of th...

ADXS - Top Penny Stocks to Watch Before The End Of The Week

Will These 5 Penny Stocks Continue Climbing This Week? While March continues to be bullish for many penny stocks, investors are always looking toward the future. With over 70 million individuals in the U.S. who have received one dose of a vaccine, investors seem confident in the pandemi...

ADXS - Advaxis reports FQ1 results

Advaxis  (ADXS): FQ1 GAAP EPS of -$0.05.Revenue of $1.62MCash and cash equivalents of ~$33.3MShares -4.31%.Press Release For further details see: Advaxis reports FQ1 results

ADXS - Advaxis Reports First Quarter Ended January 31, 2021 Financial Results and Provides a Business Update

Continued enrollment in expanded ADXS-503 HOT program in NSCLC to explore potential to enhance and/or restore sensitivity to checkpoint inhibitors ADXS-503 Phase 1/2 trial data presented at SITC demonstrated disease control rate of 67% and overall response rate of 17% in first six...

ADXS - Advaxis to Present at the American Association for Cancer Research (AACR) 2021 Annual Meeting

PRINCETON, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, and Precision for Medicine, a specialized services company supporting next generation approach...

ADXS - 5 Hot Penny Stocks To Buy Under $1 In March 2021

Are These Cheap Penny Stocks On Your List To Buy In March? Penny stocks are some of the cheapest stocks in the market. I feel like this is a given. But if you’ve been trading these cheap stocks for a while, you likely know that there are sub-sets of stocks under $5, and these are...

ADXS - Immunome, Avinger leads healthcare gainers; MEDNAX, ReWalk Robotics among major losers

Gainers: Immunome (IMNM) +93%, Avinger (AVGR) +33%, Titan Pharmaceuticals (TTNP) +17%, GBS (GBS) +15%, VistaGen Therapeutics (VTGN) +15%.Losers: MEDNAX (MD) -23%, ReWalk Robotics (RWLK) -21%, Shineco (TYHT) -19%,&...

ADXS - Advaxis gives business update and provides 2020 FY results

Clinical-stage biotech Advaxis ([[ADXS]] +1.2%) highlighted important clinical and biomarker data from the ongoing Phase 1/2 study of ADXS-503 in Nonsmall-cell lung carcinoma ((NSCLC)) during 2020, and provides full-year 2020 results.The company also talked up its clinical...

Previous 10 Next 10